Quantifying quality of life for economic analysis: Time out for time trade off

Medical Humanities

Volumn 29, Issue 2, 2003, Pages 81-86

  Arnesen, Trudivar M ^a   Norheim, O F ^b  

^a Fafo Institute for Applied International Studies   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HUMAN; LIFESPAN; LONGEVITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

EID: 0346896329     PISSN: 1468215X     EISSN: None     Source Type: Journal    
DOI: 10.1136/mh.29.2.81     Document Type: Article

References (68)

1. Williams A. Economics of coronary bypass grafting. BMJ 1985;291:326-9.
2. Weinstein MC. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716-21.
3. Busschbach JJ, Rikken B, Grobbee DE, et al. Quality of life in short adults. Horm Res 1998;49:32-8.
4. Hamel MB, Phillips RS, Davis RB, et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. Ann Intern Med 1997;127:195-202.
5. Churchill DN, Wallace JE, Ludwin D, et al. A comparison of evaluative indices of quality of life and cognitive function in hemodialysis patients. Control Clin Trials 1991;12(Suppl 4):159-67.
6. Tsevat J, Dawson NV, Wu AW, et al. Health values of hospitalized patients 80 years or older. HELP Investigators. JAMA 1998;279:371-5.
7. Nease RFJ, Kneeland T, O'Connor GT, et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 1995;273:1185-90.
8. Handler RM, Hynes LM, Nease RFJ. Effect of locus of control and consideration of future consequences on time tradeoff utilities for current health. Qual Life Res 1997;6:54-60.
9. McLeod RS, Churchill DN, Lock AM, et al. Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991;101:1307-13.
10. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:118-33.
11. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis 1987;40:593-603.
12. Neumann PJ, Zinner DE, Wright JC. Are methods for estimating QALYs in cost-effectiveness analyses improving? Med Decis Making 1997;17:402-8.
13. Murray CJL, Lopez AD. Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ 2000;9:69-82.
14. Salomon JA, Murray CJL. Estimating health state valuations using a multiple-method protocol. In: Murray CJL, Salomon JA, Mathers C, Lopez AD, eds. Summary measures of population health. Geneva: World Health Organisation, 2003:487-98.
15. Dolan P, Gudex C, Kind P, et al. Valuing health states: a comparison of methods. J Health Econ 1996;15:209-31.
16. Nord E. Methods for quality adjustment of life years. Soc Sci Med 1992;34:559-69.
17. Cruickshanks KJ, Fryback DG, Nondahl DM, et al. Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol 1999;117:461-7.
18. Russell JD, Beecroft ML, Ludwin D, et al. The quality of life in renal transplantation - a prospective study. Transplantation 1992;54:656-60.
19. National Institute of Clinical Excellence. Technical guidance for manufacturers and sponsors on making a submission to a technology appraisal. London: 2001.
20. Oldridge N, Furlong W, Feeny D, et al. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 1993;72:154-61.
21. Stolk EA, Busschbach JJ, Caffa M, et al. Cost utility analysis of sildenafil compared with papaverine-phentolamine injections. BMJ 2000;320:1165-8.
22. Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993;2:477-87.
23. Bleichrodt H, Johannesson M. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. J Health Econ 1997;16:155-75.
24. O'Leary JF, Fairclough DL, Jankowski MK, et al. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship. Med Decis Making 1995;15:132-7.
25. Read JL, Quinn RJ, Berwick DM, et al. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making 1984;4:315-29.
26. Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res 1998;29:201-9.
27. Dolan P, Sutton M. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc Sci Med 1997;44:1519-30.
28. Nord E. The validity of a visual analogue scaler in determining social utility weights for health states. Int J Health Plann Manage 1991;6:234-42.
29. Stiggelbout AM, Kiebert GM, Kievit J, et al. The "utility" of the time trade-off method in cancer patients: feasibility and proportional trade-off. J Clin Epidemiol 1995;48:1207-14.
30. Johannesson M. The ranking properties of healthy years equivalents and quality adjusted life-years under certainty and uncertainty. Int J Technol Assess Health Care 1995;11:40-8.
31. Hurny C, van W, Bacchi M, et al. Subjective health estimations (SHE) in patients with advanced breast cancer: an adopted utility concept for clinical trials. Br J Cancer 1998;77:985-91.
32. Stiggelbout AM, Kiebert GM, Kievit J, et al. Utility assessment in cancer patients: adjustment of time trade-off scores for the utility of life years and comparison with standard gamble scores. Med Decis Making 1994;14:82-90.
33. Molzahn AE, Northcott HC, Dossetor JB. Quality of life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians. ANNA J 1997;24:325-33.
34. Dolan P. Whose values count? Med Decis Making 1999;19:482-6.
35. Bala MV, Wood LL, Zarkin G, et al. Are health states "timeless"? The case of the standard gamble method. J Clin Epidemiol 1999;52:1047-53.
36. Dolan P, Gudex C, Kind P, et al. The time trade-off method: results from a general population study. Health Econ 1996;5:141-54.
37. Lundberg L, Johannesson M, Isacson DGL, et al. Health-state utilities in a general population in relation to age, gender and socioeconomic factors. Eur J Public Health 1999;9:211-17.
38. Harris J. QALYfying the value of life. J Med Ethics 1987;13:117-23.
39. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423-5.
40. McDowell I, Newell C. Assessing validity. Measuring health. A guide to rating scales and questionnaires. Oxford: Oxford University Press, 1996:30-7.
41. Guyatt GH, Naylor CD, Juniper E, et al. Users' guide to medical literature. How to use articles about health-related quality of life. JAMA 1997;277:1232-7.
42. Muldoon MF, Barger SD, Flory JD, et al. What are quality of life measurements measuring? BMJ 1998;316:542-5.
43. Wormnæs O. Vitenskapsfilosofi (Philosophy of science). Oslo: Gyldendal, 1993.
44. Perez DJ, McGee R, Campbell AV, et al. A comparison of time trade-off and quality of life measures in patients with advanced cancer. Qual Life Res 1997;6:133-8.
45. Quenec'hdu S, Hebert R. The value of autonomy in daily living activities for elderly people who have lost their autonomy [French]. Can J Aging 1995;14:706-18.
46. Daly E, Gray A, Barlow D, et al. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993;307:836-40.
47. Fryback DG, Dasbach EJ, Klein R. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993;13:89-102.
48. Bosch JL, Hunink MG. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making 1996;16:217-25.
49. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987;10:14-20.
50. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999;56:897-904.
51. Arnesen T, Trommald M. Are QALYs based on Time trade-off comparable?-A systematic review of TTO methodologies. Health Econ (in press).
52. Fowler FJ, Cleary PD, Massagli MP, et al. The role of reluctance to give up life in the measurement of the values of health states. Med Decis Making 1995;15:195-200.
53. Lockwood M. Quality of life and resource allocation. In: Bell M, Mendus S, eds. Philosophy and medical welfare. Cambridge University Press, 1988:33-55.
54. Slovic P. The constructions of preference. Am Psychol 1995;50:364-71.
55. Lenert LA, Cher DJ, Goldstein MK, et al. The effect of search procedures on utility elicitations. Med Decis Making 1998;18:76-83.
56. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life Res 1993;6:467-75.
57. Naylor CD, Llewellyn-Thomas HA. Utilities and preferences for health states: time for a pragmatic approach? J Health Serv Res Policy 1998;3:129-31.
58. Jenkinson C. Death by questionnaire: quality of life measurement could seriously damage your health. J Health Serv Res Policy 1999;4:129-30.
59. Stiggelbout AM, de Haes JC, Kiebert GM, et al. Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes. Med Decis Making 1996;16:184-92.
60. Gill T, Feinstein AR. A critical appraisal of the quality of quality-of-life-measurements. JAMA 1994;272:619-26.
61. Laupacis A, Bourne R, Rorabeck C, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993;75:1619-26.
62. Molzahn AE, Northcott HC, Hayduk L. Quality of life of patients with end stage renal disease: a structural equation model. Qual Life Res 1996;5:426-32.
63. de Wit GA, Busschlbach JJ, De CF. Senstitivity and perspective in the valuation of health status: whose values count? Health Econ 2000;9:109-26.
64. Arnesen T, Trommald M. Roughly right or precisely wrong? A systematic review of the time trade off method. J Health Serv Res Policy (in press).
65. Zethraeus N, Johannesson M, Henriksson P, et al. The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol 1997;104:1191-5.
66. Williams B. Morality. Cambridge: Cambridge University Press, 1972.
67. Rekers-Mombarg LT, Busschbach JJ, Massa GG, et al. Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatr 1998;87:865-70.
68. Oldridge N, Guyatt G, Jones N, et al. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol 1991;67:1084-9.